SAHPRA Health Product Advertising: Compliance Standards for South Africa

SAHPRA's Role in Health Product Advertising

The South African Health Products Regulatory Authority (SAHPRA) regulates the manufacture, distribution, sale, and marketing of health products in South Africa. Established under the Medicines and Related Substances Act 101 of 1965 (as amended), SAHPRA has specific authority over how medicines, medical devices, and related health products are advertised to both healthcare professionals and the public.

Health product advertising in South Africa is subject to strict controls designed to protect public health. Non-compliant advertising can result in SAHPRA enforcement action, including product seizures, licence suspensions, and criminal prosecution.

Legal Framework for Health Product Advertising

The regulatory framework governing health product advertising in South Africa includes multiple instruments:

Legislation/Regulation	Scope	Key Provisions
Medicines Act (Act 101 of 1965)	All medicines and scheduled substances	Section 18 governs advertising of medicines
General Regulations to the Medicines Act	Detailed advertising rules	Regulation 42 sets out specific advertising requirements
Medical Devices Regulations	All medical devices	Advertising must be consistent with registered intended purpose
Complementary Medicines Regulations	Complementary and traditional medicines	Specific rules on health claims and advertising
Foodstuffs, Cosmetics and Disinfectants Act	Health-related consumer products	Prohibits false or misleading claims
Marketing Code of the Pharmaceutical Industry (PCMA)	Industry self-regulation	Voluntary code adopted by industry members

Advertising to the Public vs Healthcare Professionals

South African law draws a fundamental distinction between advertising directed at the public and advertising directed at healthcare professionals:

Advertising to the Public

Only Schedule 0 medicines (unscheduled medicines available without prescription) may be advertised directly to the public
Advertising must not claim to prevent, treat, or cure any specific disease unless the claim is supported by the approved package insert
Must include the medicine's approved name and a statement advising consumers to seek medical advice if symptoms persist
Must not suggest the medicine is a food, cosmetic, or consumer product
Must not be directed at children
Must not use testimonials from healthcare professionals in a way that constitutes an endorsement

Advertising to Healthcare Professionals

May include scheduled medicines (prescription products)
Must be consistent with the approved package insert and professional information
Must present a fair balance of efficacy and safety information
Must include prescribing information with relevant contraindications and adverse effects
Must identify the source of all clinical data referenced
Must clearly identify the advertiser

Complementary Medicines Advertising

South Africa's regulatory framework for complementary medicines has undergone significant reform. SAHPRA's complementary medicines regulations require:

Health claims must be supported. Claims about the health benefits of complementary medicines must be supported by evidence appropriate to the type of claim being made.
Traditional use claims. Complementary medicines may make traditional use claims (e.g., "traditionally used for") provided there is adequate evidence of historical use.
No disease claims without registration. Complementary medicines may not claim to diagnose, treat, cure, or prevent any specific disease unless they have been registered by SAHPRA with approved indications.
Clear identification. Advertising must clearly identify the product as a complementary medicine and not create the impression that it is a registered pharmaceutical product.

Common Advertising Compliance Failures

SAHPRA monitoring and enforcement actions, along with Pharmaceutical Industry Association disciplinary proceedings, identify recurring advertising compliance issues:

Unregistered product promotion. Advertising health products that have not been registered with SAHPRA, or promoting registered products for indications not covered by their registration.

Exaggerated efficacy claims. Making claims about product performance that go beyond what is supported by the approved product information or available clinical evidence.

Inadequate safety information. Promotional materials that emphasise product benefits without adequate disclosure of side effects, contraindications, and precautions.

Misleading visual representations. Using images, graphics, or infographics that overstate product efficacy or create misleading impressions about the nature of the product.

Social media non-compliance. Health product promotion on social media platforms that does not comply with the same standards required of traditional advertising channels.

Inappropriate comparisons. Comparative advertising claims that are not supported by head-to-head clinical data or that unfairly denigrate competitor products.

The Role of Industry Self-Regulation

The Pharmaceutical Industry Association of South Africa and the Self-Medication Manufacturers Association of South Africa maintain codes of marketing practice that complement SAHPRA's regulatory requirements. These codes impose additional obligations including:

Prior review of promotional materials by qualified medical or scientific staff
Restrictions on gifts and hospitality to healthcare professionals
Requirements for scientific substantiation of all promotional claims
Complaints handling procedures for alleged code violations
Disciplinary processes for non-compliant member companies

While these codes are voluntary for member companies, compliance is often a condition of industry association membership and is increasingly referenced by SAHPRA in its regulatory guidance.

Building a SAHPRA-Compliant Content Review Process

Health product companies can reduce advertising compliance risk through structured review:

Classify all content. Determine which materials constitute advertising under the Medicines Act and identify the target audience (public vs healthcare professionals).
Verify registration status. Confirm that every product being advertised is registered with SAHPRA and that all claims fall within the approved indications.
Check against package insert. Verify that all efficacy and safety claims are consistent with the approved package insert and professional information.
Ensure balance. Review promotional materials to confirm that benefit claims are balanced with appropriate safety information.
Review digital channels. Apply the same compliance standards to social media, website, and email content as to print and broadcast advertising.
Maintain substantiation files. Keep organised files of clinical and scientific evidence supporting every claim in advertising materials.

How Content Review Tools Support SAHPRA Compliance

AI-powered content review can help South African health product companies maintain advertising compliance by checking content against approved product information, flagging unsupported claims, ensuring mandatory disclosures are present, and verifying balance between benefit and safety information. Automated review is particularly valuable for companies managing advertising across multiple products, indications, and communication channels.

Structured content review creates a documented quality assurance process that demonstrates due diligence in advertising compliance, supporting the company's position during SAHPRA inspections or industry code proceedings.

Key Takeaways

Health product advertising in South Africa is subject to strict regulatory controls designed to protect public health. SAHPRA and industry codes impose detailed requirements on what can be communicated, to whom, and through which channels. Companies that invest in structured content review processes ensure their advertising meets regulatory standards, protect public health, and maintain their commercial standing in a highly regulated market.